NCT01328418COMPLETEDanonymous

Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

Sponsor

Source record

Bilen, Fikri Erkal, M.D.

Phase

Source record

Modality

AI-normalized

RNA therapy

Target

AI-normalized

Lengthening over nail

Indication / condition

AI-normalized

SHOX Gene With Short Stature

Intervention

Source record

Lengthening over nail

Related intelligence directories

Indication directory: SHOX Gene With Short Stature Modality directory: RNA therapy Target directory: Lengthening over nail

Source & freshness

Source record

NCT ID

NCT01328418

Original source

ClinicalTrials.gov

Source last updated

Apr 04, 2011

Ingested at

Jun 20, 2026

Internal sync

Jun 20, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT01328418

Title

Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

Sponsor

Bilen, Fikri Erkal, M.D.

Status

COMPLETED

Phase

Condition raw

SHOX Gene With Short Stature

Condition normalized

SHOX Gene With Short Stature

Modality raw

RNA therapy

Modality normalized

RNA therapy

Target raw

Lengthening over nail

Target normalized

Lengthening over nail

Interventions

Lengthening over nail

Public preview

Source record

The purpose of this study is to determine whether lengthening of both the tibiae and femora in achondroplastic patients is safe and provides reproducible outcome.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT01328418

Status

COMPLETED

Phase

Sponsor

Bilen, Fikri Erkal, M.D.

Executive brief

Investment-Ready Snapshot

The purpose of this study is to determine whether lengthening of both the tibiae and femora in achondroplastic patients is safe and provides reproducible outcome.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedApr 04, 2011

Internal syncJun 20, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01328418

Indication

SHOX Gene With Short Stature

Modality

RNA therapy

Target

Lengthening over nail

Intervention

Lengthening over nail

Source record